San Francisco, CA, United States of America

Mark Eamon Hayes

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 71(Granted Patents)


Location History:

  • San Francisco, CA (US) (2013 - 2024)
  • Mill Valley, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Mark Eamon Hayes: Pioneer in Lipid Nanoparticle Technology

Introduction

Mark Eamon Hayes is an innovative inventor based in San Francisco, California, known for his significant contributions to the field of biomedicine. With a prolific portfolio of 16 patents, Hayes focuses on advancing the delivery mechanisms of therapeutic nucleic acids through lipid nanoparticles, pushing the boundaries of modern medicine.

Latest Patents

Hayes's latest patents include groundbreaking work on "Lipid nanoparticles for delivery of nucleic acids and methods of use thereof." This patent describes improved compositions of ionizable lipid nanoparticles designed for delivering therapeutic nucleic acids to cells. These cationic ionizable lipids possess enhanced stability against oxidative degradation while maintaining high transfection potency in cellular environments. Additionally, these biodegradable lipids increase the tolerability of nanoparticles in vivo and are engineered to target dendritic cells with high specificity using antibody conjugates aimed at cell surface receptors. Another notable patent by Hayes is focused on providing compounds useful as ionizable cationic lipids for preparing lipid nanoparticles, emphasizing the potential of these engineered lipids in therapeutic applications.

Career Highlights

Throughout his career, Mark Eamon Hayes has held positions in several esteemed companies, including Zoneone Pharma, Inc. and Akagera Medicines, Inc. His work at these organizations has been instrumental in enhancing lipid-based delivery systems, showcasing his commitment to solving complex challenges in drug delivery.

Collaborations

During his journey as an inventor, Hayes has collaborated with notable coworkers such as Dmitri B Kirpotin and Daryl C Drummond. Their collective expertise has undoubtedly strengthened the innovative undertakings within the projects they have worked on together.

Conclusion

Mark Eamon Hayes stands as a leading figure in the field of lipid nanoparticles, contributing to transformative advancements in the delivery of therapeutic nucleic acids. Through his innovative patents and collaborations, he continues to play a crucial role in the evolution of biomedicine, illustrating the impact of dedicated inventors in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…